Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations by Li, Yan et al.
ISSN: 1524-4563 
Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0194-911X. Online
72514
Hypertension is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX
DOI: 10.1161/HYPERTENSIONAHA.109.137273 
 published online Mar 8, 2010; Hypertension
Investigators 
on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes 
Ibsen, Yutaka Imai, Jiguang Wang, Jan A. Staessen and for the International Database
Edoardo Casiglia, Yuri Nikitin, Edgardo Sandoya, Kalina Kawecka-Jaszcz, Hans 
Kuznetsova, Katarzyna Stolarz-Skrzypek, Valérie Tikhonoff, Sofia Malyutina,
Richart, Hirohito Metoki, Takayoshi Ohkubo, Christian Torp-Pedersen, Tatiana 
Yan Li, Lutgarde Thijs, Tine W. Hansen, Masahiro Kikuya, José Boggia, Tom
 Populations
Prognostic Value of the Morning Blood Pressure Surge in 5645 Subjects From 8
http://hyper.ahajournals.org/cgi/content/full/HYPERTENSIONAHA.109.137273/DC1
Data Supplement (unedited) at: 
 
 http://hyper.ahajournals.org
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
 http://www.lww.com/reprints
Reprints: Information about reprints can be found online at 
  
 journalpermissions@lww.com
410-528-8550. E-mail: 
Fax:Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. 
Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters
  
 http://hyper.ahajournals.org/subscriptions/
Subscriptions: Information about subscribing to Hypertension is online at 
 by JAN STAESSEN on March 8, 2010 hyper.ahajournals.orgDownloaded from 
Epidemiology/Population Studies
Prognostic Value of the Morning Blood Pressure Surge in
5645 Subjects From 8 Populations
Yan Li, Lutgarde Thijs, Tine W. Hansen, Masahiro Kikuya, Jose´ Boggia, Tom Richart,
Hirohito Metoki, Takayoshi Ohkubo, Christian Torp-Pedersen, Tatiana Kuznetsova,
Katarzyna Stolarz-Skrzypek, Vale´rie Tikhonoff, Sofia Malyutina, Edoardo Casiglia, Yuri Nikitin,
Edgardo Sandoya, Kalina Kawecka-Jaszcz, Hans Ibsen, Yutaka Imai, Jiguang Wang, Jan A. Staessen,
for the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular
Outcomes Investigators
Abstract—Previous studies on the prognostic significance of the morning blood pressure surge (MS) produced inconsistent
results. Using the International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcome, we
analyzed 5645 subjects (mean age: 53.0 years; 54.0% women) randomly recruited in 8 countries. The sleep-through and
the preawakening MS were the differences in the morning blood pressure with the lowest nighttime blood pressure and
the preawakening blood pressure, respectively. We computed multivariable-adjusted hazard ratios comparing the risk in
ethnic- and sex-specific deciles of the MS relative to the average risk in the whole study population. During follow-up
(median: 11.4 years), 785 deaths and 611 fatal and nonfatal cardiovascular events occurred. While accounting for
covariables and the night:day ratio of systolic pressure, the hazard ratio of all-cause mortality was 1.32 (95% CI: 1.09
to 1.59; P0.004) in the top decile of the systolic sleep-through MS (37.0 mm Hg). For cardiovascular and
noncardiovascular death, these hazard ratios were 1.18 (95% CI: 0.87 to 1.61; P0.30) and 1.42 (95% CI: 1.11 to 1.80;
P0.005). For all cardiovascular, cardiac, coronary, and cerebrovascular events, the hazard ratios in the top decile of
the systolic sleep-through MS were 1.30 (95% CI: 1.06 to 1.60; P0.01), 1.52 (95% CI: 1.15 to 2.00; P0.004), 1.45
(95% CI: 1.04 to 2.03; P0.03), and 0.95 (95% CI: 0.68 to 1.32; P0.74), respectively. Analysis of the preawakening
systolic MS and the diastolic MS generated consistent results. In conclusion, a MS above the 90th percentile
significantly and independently predicted cardiovascular outcome and might contribute to risk stratification by
ambulatory blood pressure monitoring. (Hypertension. 2010;55:1040-1048.)
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Several studies showed that the incidence of cardiovascu-lar complications peaks in the morning.1,2 For instance, in
the Multicenter Investigation of Limitation of Infarct Size
Study1 and in the Thrombolysis in Myocardial Infarction
Phase II Trial,2 the incidence of myocardial infarction was
highest between 6:00 AM and 12:00 AM. Blood pressure also
follows a circadian pattern, generally characterized by a fall
during sleep and a sharp rise on awakening.3 This observation
gave rise to the hypothesis that an exaggerated morning surge
of blood pressure might predict cardiovascular outcome.
However, previous studies of populations4 and hypertensive
patients5–7 produced contradictory results, possibly because
of the small number of events and the lack of statistical
power. A further issue complicating the interpretation of
previous studies is the varying definitions of the morning
surge in blood pressure.8
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With the goal to advance knowledge on the prognostic
accuracy of the ambulatory blood pressure, a research con-
sortium constructed the International Database of Ambula-
tory Blood Pressure in Relation to Cardiovascular Out-
come.9–12 We used this resource to study whether the
morning surge in blood pressure contributes to the stratifica-
tion of cardiovascular risk.
Methods
Study Population
Previous publications (for details, see the Expanded Methods in the
online Data Supplement, available at http://hyper.ahajournals.org)
described the construction of the International Database of Ambu-
latory Blood Pressure in Relation to Cardiovascular Outcome.9–12 At
the time of writing this report, the International Database of
Ambulatory Blood Pressure in Relation to Cardiovascular Outcome
included prospective studies from 11 centers (11 786 subjects). All
studies received ethical approval and have been reported in peer-
reviewed publications. For the present analysis, we selected studies
in which the participants completed a diary during ambulatory blood
pressure monitoring, leaving 8 cohorts13–19 and 9488 subjects for
possible analysis. In line with previous reports,9–12 we excluded 250
participants because they were 18 years of age and 2430 partici-
pants because they had10 daytime or5 nighttime blood pressure
readings. For the analysis of the morning surge, we additionally
disregarded 1163 subjects because they had2 blood pressure readings
during the 2 hours before (n122) or after awakening (n1041). Thus,
the current analysis included 5645 participants: 1685 residents from
Copenhagen, Denmark13; 532 subjects from Noorderkempen, Bel-
gium14; 220 subjects from Novosibirsk, Russia15,16; 290 subjects from
Padova, Italy16; 296 subjects from Krako´w, Poland16; 1396 inhabitants
from Ohasama, Japan17; 327 villagers from the JingNing county,
China18; and 899 subjects from Montevideo, Uruguay.19 All participants
gave informed written consent.
Blood Pressure Measurement
Conventional blood pressure was measured by trained observers with
a mercury sphygmomanometer,13–16,18 with validated auscultatory17
(USM-700F, UEDA Electronic Works), or oscillometric19 (OMRON
HEM-705CP, Omron Corporation) devices, using the appropriate
cuff size, with the participants in the sitting position.13–19 Conven-
tional blood pressure was the average of 2 consecutive readings
obtained either at the person’s home14–16,18,19 or at an examination
center.13,17 Hypertension was a conventional blood pressure of
140 mm Hg systolic, 90 mm Hg diastolic, or the use of antihy-
pertensive drugs.
We programmed portable monitors to obtain ambulatory blood
pressure readings at 30-minute intervals throughout the whole day17
or at intervals ranging from 1513 to 2014–16,18 minutes during daytime
and from 3017 to 6013 minutes at night (for details, see the Expanded
Methods available in the online Data Supplement). When accounting
for the daily pattern of activities of the participants, we defined
daytime as the interval ranging from 10:00 AM to 8:00 PM in
Europeans13–16 and South Americans,19 and from 8:00 AM to 6:00 PM
in Asians.17,18 The corresponding nighttime intervals ranged from
12:00 AM to 6:00 AM13–16,19 and from 10:00 PM to 4:00 AM.17,18
Within individual subjects, we weighted the means of the ambulatory
blood pressure level by the interval between readings. To quantify
the nocturnal fall in blood pressure, we computed the night:day
blood pressure ratio from the nighttime and daytime blood pressures.
For analysis of the morning surge in blood pressure, we deter-
mined the awake and asleep periods from the subjects’ diary cards.
Subjects were asked to record the time when they got up in the
morning and went to bed at night. The sleep-through morning surge
was the difference between the morning pressure (the average blood
pressure during the 2 hours after awakening) and the lowest
nighttime blood pressure (the average of the lowest pressure and the
2 readings immediately preceding and after the lowest value).5 The
preawakening morning surge was the difference between the morn-
ing blood pressure (the average blood pressure during the 2 hours
after awakening) and the preawakening blood pressure (the average
blood pressure during the 2 hours before awakening).4,5
Other Measurements
We used the questionnaires originally administered in each cohort to
obtain information on each subject’s medical history and smoking
and drinking habits. Body mass index was body weight in kilograms
divided by height in meters squared. We measured serum cholesterol
and blood glucose by automated enzymatic methods. Diabetes
mellitus was the use of antidiabetic drugs, a fasting blood glucose
concentration of 7.0 mmol/L,13–19 a random blood glucose con-
centration of 11.1 mmol/L,14,17,18 a self-reported diagnosis,14,18,19
or diabetes mellitus documented in practice or hospital records.19
Ascertainment of Events
We ascertained vital status and the incidence of fatal and nonfatal
diseases from the appropriate sources in each country, as described
in previous publications (for details, see the Expanded Methods
available in the online Data Supplement).9,17,20–23 Fatal and nonfatal
stroke did not include transient ischemic attacks. Coronary events
encompassed death from ischemic heart disease, sudden death,
nonfatal myocardial infarction, and coronary revascularization. Car-
diac events consisted of coronary events and fatal and nonfatal heart
failure. Cardiovascular events included all aforementioned events
plus cardiovascular mortality. In all outcome analyses, we consid-
ered only the first event within each category.
Statistical Analysis
For database management and statistical analysis, we used SAS
software, version 9.1.3 (SAS Institute). We compared means and
proportions by the large-sample z test and the 2 statistic, respec-
tively. Statistical significance was a 2-sided P value of 0.05.
We used Kaplan-Meier survival function estimates and the log-
rank test to compare the incidence rates of events in the top decile of
the distributions of the sleep-through and preawakening morning
surge with the rates in the rest of the study population. We used Cox
regression to compute hazard ratios. We checked the proportional
hazards assumption by the Kolmogorov-type supremum test, as
implemented in the PROC PHREG procedure of the SAS package.
Because the relation between cardiovascular complications and the
morning surge in blood pressure was not linear, we used the
deviation from the population mean coding24 to estimate the risk in
the ethnic- and sex-specific deciles of the sleep-through and
preawakening morning surge. This approach expresses the risk in
each decile relative to the overall risk in the whole study population
and allows computation of CIs for the hazard ratio in each decile
without definition of an arbitrary reference group. In an attempt to
refine the level of the morning surge that was associated with a
significantly increased risk, we calculated for all cutoff points
ranging from the fifth to the 95th percentile the hazard ratio
expressing the risk in subjects whose morning surge exceeded the
cutoff point versus the risk in the total study population. We plotted
these hazard rates and their confidence limits versus the cutoff points
and identified the cutoff point where the lower confidence limit
crossed unity. We adjusted the hazard ratios for baseline characteristics,
including cohort, sex, age, body mass index, the 24-hour blood pressure
level, current smoking, use of alcohol, serum cholesterol, the presence
of diabetes mellitus, a history of cardiovascular disease, and antihyper-
tensive treatment. In fully adjusted models, the night:day blood pres-
sure ratio was additionally included. In sensitivity analyses, we
compared the hazard ratios according to baseline characteristics,
using a normal approximation of the log-transformed point estimates
and SEs.
Results
Characteristics of Participants
The 5465 participants included 3023 Europeans (53.6%),
1723 Asians (30.5%), and 899 South Americans (15.9%). Of
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the 5645 participants, 3048 were women (54.0%), 1188
(21.1%) were taking blood pressure–lowering drugs, and
2305 (40.8%) had hypertension. MeanSD age was
53.014.7 years. In the whole study population, the 24-hour
blood pressure averaged 123.313.5 mm Hg systolic and
73.78.6 mm Hg diastolic. At enrollment, 1690 participants
(29.9%) were current smokers, and 2667 (47.3%) reported
intake of alcohol.
The median number of blood pressure readings (fifth to
95th percentile interval) used for the calculation of the
within-subject preawakening blood pressure was 5 (2 to 9)
and 4 (2 to 6) for the within-subject morning blood pressure.
In all participants, the sleep-through and preawakening morn-
ing surge in systolic blood pressure averaged 20.712.9 and
13.111.9 mm Hg, respectively. However, there were signif-
icant ethnic and sex differences in the morning blood pressure
surge. The mean values of the sleep-through systolic morning
surge in the top decile were smaller in women than in men
among Europeans (40.9 versus 43.2 mm Hg; P0.003) and
South Americans (38.8 versus 41.5 mm Hg; P0.041),
whereas the opposite was the case among Asians (52.4 versus
50.1 mm Hg; P0.064). For the preawakening systolic morn-
ing surge, the differences between women and men showed
similar trends: 26.8 versus 29.2 mm Hg (P0.062), 22.5
versus 26.9 mm Hg (P0.059), and 30.6 versus 27.4 mm Hg
(P0.13) in Europeans, South Americans, and Asians, re-
spectively. These differences explain why we applied
ethnicity- and sex-specific deciles to study the predictive
value of the morning blood pressure surge. This also ensured
an equal distribution of ethnicities and women and men
across the deciles.
Table 1 shows the baseline characteristics of the partici-
pants categorized according to the 90th percentile of the
sleep-through morning surge in systolic blood pressure.
These 2 groups had significantly different characteristics
(P0.05), with the exception of the nighttime systolic pres-
sure (P0.35); the proportions of Europeans, Asians, and
South Americans (P0.89); and the percentages of women
(P0.93), smokers (P0.12), and drinkers (P0.51).
Incidence of Events
In the overall study population, median follow-up was 11.4
years (fifth to 95th percentile interval: 2.5 to 15.5 years).
Across cohorts, median follow-up ranged from 2.5 years
(fifth to 95th percentile interval: 2.3 to 2.6 years) in JingNing
to 13.3 years (fifth to 95th percentile interval: 4.7 to 16.3
years) in Noorderkempen. During 57 412 person-years of
follow-up, 785 participants died (13.7 per 1000 person-
years), and 611 experienced a fatal or nonfatal cardiovascular
complication (11.0 per 1000 person-years).
Mortality included 287 cardiovascular and 473 noncardio-
vascular deaths and 25 deaths from unknown cause. Consid-
ering cause-specific cardiovascular events, 281 patients ex-
perienced a fatal or nonfatal stroke. The first cerebrovascular
event was fatal in 69 subjects. Of the 281 fatal and nonfatal
cerebrovascular events, 140 were brain infarcts and 70 were
hemorrhagic strokes, whereas the stroke subtype was un-
known in 71 cases. Stroke occurred in 76 Europeans, 181
Asians, and 24 South Americans. Fatal or nonfatal cardiac
events occurred in 317 subjects. The first cardiac event was
fatal in 102 subjects. The 317 cardiac events included 47 fatal
and 88 nonfatal cases of acute myocardial infarction, 20
sudden deaths, 10 deaths from ischemic heart diseases, 25
fatal and 84 nonfatal cases of heart failure, and 43 cases of
surgical or percutaneous coronary revascularization. Of 317
fatal and nonfatal cardiac events, 222 occurred in Europeans,
43 in Asians, and 52 in South Americans.
Risk Associated With Sleep Trough and
Preawakening Morning Surge
Figure 1 shows the Kaplan-Meier survival function estimates
for total mortality and for all fatal combined with nonfatal
cardiovascular events in subjects categorized according to the
90th percentile of the sleep-through and the preawakening
morning surge in systolic blood pressure. The results for the
morning surge in diastolic blood pressure were similar to that
of systolic pressure. In this article, we, therefore, limit the
presentation of the results to systolic blood pressure, whereas
those for diastolic blood pressure appear in the online Data
Supplement (Tables S1 through S3).
The morning surge in blood pressure varies with the
difference between the daytime and nighttime blood pres-
Table 1. Baseline Characteristics of the Participants
Categorized According to the 90th Percentile of the Systolic
Sleep-Through Morning Surge
Characteristics
Sleep-Through Morning Surge
P37.0 mm Hg* 37.0 mm Hg*
Total, n 5075 570
European 2718 (53.6) 305 (53.5) 0.99
Asian 1550 (30.5) 173 (30.3) 0.92
South American 807 (15.9) 92 (16.1) 0.90
Women 2739 (54.0) 309 (54.2) 0.93
Antihypertensive treatment 992 (19.6) 196 (34.4) 0.0001
Smokers 1503 (29.6) 187 (32.8) 0.12
Using alcohol 2390 (47.1) 277 (48.6) 0.51
Diabetes mellitus 334 (6.6) 51 (9.0) 0.04
Cardiovascular disorders 348 (6.9) 56 (9.8) 0.01
Age, y 52.514.6 57.714.5 0.0001
Body mass index, kg/m2 25.14.2 25.74.6 0.001
Conventional SBP, mm Hg 128.719.3 138.021.7 0.0001
Ambulatory SBP, mm Hg
24-hour 122.613.4 129.713.3 0.0001
Daytime 128.914.3 137.614.2 0.0001
Nighttime 111.814.4 112.415.0 0.35
Nighttime through 105.613.9 101.213.8 0.0001
Preawakening 112.215.9 117.918.3 0.0001
After awakening 123.715.4 145.815.2 0.0001
Night:day ratio of SBP 0.870.08 0.820.08 0.0001
Serum cholesterol, mmol/L 5.551.19 5.681.15 0.01
The 90th percentiles were determined after stratification for ethnicity and
sex. Data are No. (%) or meanSD. SBP indicates systolic blood pressure. P
values are for the difference between the 2 groups.
*Mean value of the cutoff point across ethnicities and sex weighted for the
No. of participants in each of the strata.
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sures.1–4 We, therefore, analyzed the prognostic significance
of the morning surge in blood pressure with and without
additional adjustment for the night:day blood pressure ratio
(Table 2) while accounting for other risk factors. With
adjustments applied for cohort, sex, age, body mass index, the
24-hour systolic blood pressure, current smoking, use of
alcohol, serum cholesterol, the presence of diabetes mellitus,
a history of cardiovascular disease, and antihypertensive drug
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Figure 1. Cumulative incidence of total mor-
tality (A and C) and all cardiovascular (CV)
events (B and D) in subjects categorized
according to the 90th percentile of the sleep-
through (A and B) and the preawakening (C
and D) morning surge in systolic blood pres-
sure. P values are for the differences
between the 2 groups by the log-rank test.
Table 2. Multivariable-Adjusted Hazard Ratios for the Sleep-Through and Preawakening Morning Surge in
Systolic Blood Pressure
Outcomes (No. of Events)
Sleep-Through Surge (37.0 mm Hg) Preawakening Surge (28.0 mm Hg)
Adjusted Fully Adjusted Adjusted Fully Adjusted
Mortality
All causes (785) 1.18 (0.99 to 1.42) 1.32 (1.09 to 1.59)† 1.11 (0.91 to 1.35) 1.23 (1.00 to 1.51)*
Cardiovascular (287) 1.06 (0.78 to 1.43) 1.18 (0.87 to 1.61) 1.08 (0.78 to 1.51) 1.22 (0.87 to 1.71)
Noncardiovascular (473) 1.28 (1.01 to 1.61)* 1.42 (1.11 to 1.80)† 1.13 (0.87 to 1.46) 1.23 (0.95 to 1.61)
Fatal and nonfatal events
All cardiovascular (611) 1.18 (0.97 to 1.44) 1.30 (1.06 to 1.60)* 1.31 (1.06 to 1.61)† 1.45 (1.17 to 1.80)‡
Cardiac (317) 1.36 (1.04 to 1.78)* 1.52 (1.15 to 2.00)† 1.52 (1.14 to 2.01)† 1.69 (1.26 to 2.27)‡
Coronary (228) 1.35 (0.98 to 1.85) 1.45 (1.04 to 2.03)* 1.50 (1.08 to 2.09)* 1.64 (1.16 to 2.49)†
Cerebrovascular (281) 0.89 (0.65 to 1.23) 0.95 (0.68 to 1.32) 1.04 (0.75 to 1.44) 1.13 (0.81 to 1.58)
Infarction (140) 0.79 (0.49 to 1.27) 0.85 (0.52 to 1.39) 1.26 (0.82 to 1.92) 1.46 (0.93 to 2.30)
Hemorrhage (70) 1.57 (0.90 to 2.73) 1.46 (0.81 to 2.63) 1.18 (0.64 to 2.18) 1.11 (0.59 to 2.11)
Hazard ratios (95% CIs) express the risk in the top decile of the sleep-through or preawakening morning surge in systolic blood
pressure compared with the overall risk in the whole study population. The Cox models included cohort, sex, age, body mass index,
smoking and drinking, serum cholesterol, history of cardiovascular disease, diabetes mellitus, antihypertensive drug treatment,
24-hour systolic blood pressure, and 9 design variables coding for the deciles. In fully adjusted models, the systolic night:day blood
pressure ratio was additionally included in the Cox model. The cause of death was unknown in 25 cases.
*P0.05 hazard ratio significance.
†P0.01 hazard ratio significance.
‡P0.001 hazard ratio significance.
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treatment, the risk of noncardiovascular mortality (P0.04)
and of all fatal combined with nonfatal cardiac events
(P0.03) was significantly higher in the top decile of the
sleep-through morning surge compared with the average risk
in the whole study population (Table 2). When further
adjusted for the night:day ratio of systolic blood pressure, the
risk of all-cause mortality was 32% (P0.004) higher in the
top decile of the sleep-through morning surge. For cardiovas-
cular and noncardiovascular death, these estimates were 18%
(P0.30) and 42% (P0.005) and for all cardiovascular,
cardiac, coronary, and cerebrovascular events, 30%
(P0.01), 52% (P0.004), 45% (P0.03), and 5%
(P0.74), respectively (Table 2). Figure 2 shows the fully
adjusted hazard ratios for all-cause mortality and for all fatal
combined with nonfatal cardiovascular events by deciles of
the morning blood pressure surge. Only in the top decile
group was the risk significantly higher than the average risk
in the whole population, whereas in the 50th percentile
group, the risk was significantly lower by 35% (P0.01)
for all-cause mortality and for all cardiovascular events
(Figure 2).
Compared with our findings for the systolic sleep-through
morning surge, analysis of the systolic preawakening morning
surge produced confirmatory results. While accounting for
covariables and the night:day ratio of systolic pressure, subjects
in the top decile group of the systolic preawakening morning
surge had an increased risk of all-cause mortality (23%;
P0.049) and of all cardiovascular (45%; P0.0008), cardiac
(69%; P0.0004), and coronary (64%; P0.01) events com-
pared with the average risk in the whole study population.
In an attempt to define in a more precise manner cutoff
points for risk stratification in clinical practice, we explored
the risk associated with all values of the sleep-through and
preawakening morning surge in systolic blood pressure
within the fifth to 95th percentile interval. The overall risk in
the whole study population was used as a reference (Figure 3).
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Figure 2. Multivariable-adjusted hazard ratios (95% CIs) for all-cause mortality (A and C) and for all fatal combined with nonfatal cardiovas-
cular (CV) events (B and D) by ethnic- and sex-specific deciles of the sleep-through (A and B) and the preawakening (C and D) morning surge
in systolic blood pressure in 5645 subjects. The hazard ratios express the risk in deciles compared with the average risk in the whole study
population and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular dis-
ease, diabetes mellitus, antihypertensive drug treatment, 24-hour systolic blood pressure, and the systolic night:day blood pressure ratio. The
number of events and incidence rates (events per 1000 person-years) are also given for each decile.
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For the sleep-through morning surge in systolic blood pres-
sure, the lower boundary of the 95% CI of the risk function
crossed unity of the hazard ratio at 24.6 and 20.9 mm Hg for
total mortality and all cardiovascular events, respectively. For
the preawakening morning surge in systolic blood pressure,
these crossings occurred at 22.7 mm Hg and 21.5 mm Hg,
respectively. The results of these analyses suggest that, for
both measures of the morning surge in systolic blood pres-
sure, a value 20 mm Hg is probably not associated with
increased risk (Figure 3).
Sensitivity Analyses
We checked the consistency of our results for total mortality
and all cardiovascular events according to various baseline
characteristics (Table 3). The hazard ratios expressing the risk
in the top decile of the systolic morning surge were not
statistically different across strata (0.12P0.98) with 2
exceptions. Irrespective of the definition of the morning surge
in systolic blood pressure, in the top decile, smokers had a
significantly higher risk for all-cause mortality than non-
smokers (P0.013). The hazard ratios of all cardiovascular
events for the sleep-through morning surge between drinkers
and nondrinkers in the top decile were also different
(P0.04). However, the power to detect heterogeneity be-
tween strata was low. For example, considering a 2-sided
-level of 0.05, we had only 28% power to detect a 0.23
difference between women and men in the log-transformed
hazard ratio of all-cause mortality for the sleep-through
morning surge.
Discussion
Our current meta-analysis of individual data included 5000
people randomly recruited from 8 populations and covered on
average 10 years of follow-up, during which 785 people died
and 611 experienced a major cardiovascular complication.
The key finding was that, while accounting for the night:day
blood pressure ratio, the 24-hour blood pressure level, and
other covariables, a morning surge in blood pressure exceed-
ing the 90th percentile was a significant and independent
predictor of mortality and cardiovascular events.
Ambulatory blood pressure monitoring enables testing of
the hypothesis that the diurnal variation in the incidence of
cardiovascular complications, such as stroke and myocardial
infarction, tracks with changes in the blood pressure level.25
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Figure 3. Multivariable-adjusted hazard ratios (solid lines) and their 95% CIs (dashed lines) for all-cause mortality (A and C) and for all
fatal combined with nonfatal cardiovascular (CV) events (B and D) by cutoff points ranging from the fifth to 95th percentile for the
sleep-through (A and B) and preawakening (C and D) morning surge in systolic blood pressure in 5645 subjects. The hazard ratios
express the risk in subjects whose morning surge exceeds the cutoff point compared with the average risk in the whole study popula-
tion. The hazard ratios were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of car-
diovascular disease, diabetes mellitus, antihypertensive drug treatment, 24-hour systolic blood pressure, and the systolic night:day
blood pressure ratio.
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The seminal article by Kario et al,5 published in 2003,
introduced the definitions of the sleep-through and preawak-
ening morning surge in blood pressure as a way to study the
risk associated with the rise in blood pressure on awakening.
In 519 older hypertensive patients (mean age: 72 years)
followed up for 41 months, Kario et al5 compared the risk of
silent and clinical cerebrovascular diseases in the top decile
(55 mm Hg) of the systolic sleep-through morning surge
with the risk in the other patients. After matching for age and
the 24-hour blood pressure, the risk of multiple brain infarcts
was 2-fold higher in patients belonging to the top decile of
the systolic sleep-through morning surge. Moreover, with
adjustment for the 24-hour blood pressure, nocturnal dipping
status, and the prevalence of silent infarcts at enrollment, the
morning surge remained a significant predictor of stroke.5
In 1430 subjects (mean age: 61 years; 64% women) randomly
recruited from the Ohasama population, 128 cerebrovascular
events occurred during a mean follow-up of 10.4 years.4 The
cerebrovascular complications included 86 ischemic strokes and
27 cases with intracerebral hemorrhage. With adjustments ap-
plied for the 24-hour systolic blood pressure and other cardio-
vascular risk factors, the preawakening morning surge in systolic
pressure tended to be associated with an increased risk of
cerebral hemorrhage (hazard ratio per 1 SD increase: 1.34; 95%
CI: 0.95 to 1.89) but not with the risk of ischemic stroke
(hazard ratio per 1 SD increase: 0.97; 95% CI: 0.79 to 1.19).
The predictive value of the sleep-through morning surge was
broadly similar to that of the preawakening morning surge.4
Gosse et al6 studied 507 untreated hypertensive patients
without complications at enrollment. The average follow-up
of these patients was 92 months, during which 31 cardiovas-
cular events including 6 deaths occurred. The morning surge
was the difference between the first systolic measurement
after standing up in the morning and the last systolic value
within the 30 minutes before assuming a standing position in
the morning. A 1-mm Hg increase in the morning surge,
adjusted for the 24-hour systolic blood pressure and age, was
associated with a 3.3% increase (95% CI: 0.8% to 5.8%) in
the risk of cardiovascular events.6
An exaggerated morning surge in blood pressure potentially
originates from a low nighttime-through blood pressure and/or a
high blood pressure after awakening. We therefore presented the
hazard ratios with and without additional adjustment for the
night:day blood pressure ratio (Table 2). Including this ratio in
the multivariable Cox models yielded higher hazard ratios for
total mortality and for all cardiovascular, cardiac, and coronary
events compared with those in Cox models not including the
night:day blood pressure ratio.
Similarly as in previous reports,4–6 subjects belonging to
the top decile of the distribution of the morning surge in
Table 3. Multivariable-Adjusted Hazard Ratios for the Sleep-Through and Preawakening Morning Surge in Systolic Blood Pressure
According to Baseline Characteristics
Stratification
All-Cause Mortality All Cardiovascular Events
At
Risk, n
Deaths,
n
Sleep-Through MS
(37.0 mm Hg)
Preawakening MS
(28.0 mm Hg)
Events,
n
Sleep-Through MS
(37.0 mm Hg)
Preawakening MS
(28.0 mm Hg)
All participants 5645 785 1.32 (1.09 to 1.59)† 1.23 (1.00 to 1.51)* 611 1.30 (1.06 to 1.60)* 1.45 (1.17 to 1.80)‡
Women 3048 321 1.15 (0.86 to 1.54) 1.20 (0.88 to 1.64) 251 1.07 (0.78 to 1.49) 1.34 (0.96 to 1.87)
Men 2597 464 1.45 (1.14 to 1.86)† 1.28 (0.98 to 1.68) 360 1.49 (1.14 to 1.95)† 1.54 (1.15 to 2.05)†
60 years 3558 134 1.27 (0.75 to 2.15) 1.22 (0.75 to 2.01) 151 1.35 (0.86 to 2.12) 1.36 (0.88 to 2.08)
60 years 2087 651 1.31 (1.07 to 1.61)† 1.22 (0.98 to 1.53) 460 1.28 (1.01 to 1.62)* 1.46 (1.14 to 1.88)†
No history of CVD 5241 660 1.28 (1.04 to 1.58)* 1.18 (0.94 to 1.47) 501 1.23 (0.98 to 1.56) 1.46 (1.16 to 1.85)†
History of CVD 404 125 1.74 (1.10 to 2.77)* 1.83 (1.10 to 3.04)* 110 1.64 (1.01 to 2.66)* 1.71 (0.99 to 2.94)
Untreated 4457 464 1.22 (0.93 to 1.58) 1.16 (0.89 to 1.51) 332 1.11 (0.82 to 1.51) 1.41 (1.06 to 1.87)*
Treated 1188 321 1.43 (1.09 to 1.89)* 1.35 (0.98 to 1.87) 279 1.46 (1.09 to 1.95)* 1.49 (1.07 to 2.08)*
Normotensive 3340 290 1.55 (1.11 to 2.16)* 1.27 (0.92 to 1.76) 178 1.54 (1.01 to 2.34)* 1.61 (1.11 to 2.34)*
Hypertensive 2305 495 1.28 (1.02 to 1.61)* 1.25 (0.96 to 1.63) 433 1.26 (0.99 to 1.60) 1.39 (1.07 to 1.82)*
Nonsmokers 3955 485 1.08 (0.84 to 1.39)§ 0.91 (0.68 to 1.23)§ 389 1.12 (0.86 to 1.47) 1.21 (0.90 to 1.62)
Smokers 1690 300 1.75 (1.31 to 2.33)‡§ 1.79 (1.34 to 2.39)‡§ 222 1.59 (1.14 to 2.22)† 1.84 (1.32 to 2.56)‡
Nondrinkers 2978 409 1.15 (0.87 to 1.51) 1.13 (0.84 to 1.51) 318 1.06 (0.78 to 1.43)§ 1.32 (0.98 to 1.78)
Drinkers 2667 376 1.48 (1.14 to 1.91)† 1.36 (1.02 to 1.81)* 293 1.62 (1.22 to 2.14)‡§ 1.64 (1.20 to 2.24)†
European 3023 408 1.38 (1.06 to 1.80)* 1.24 (0.93 to 1.65) 304 1.53 (1.15 to 2.05)† 1.83 (1.36 to 2.45)‡
Asian 1723 319 1.37 (1.03 to 1.84)* 1.24 (0.91 to 1.70) 234 1.17 (0.83 to 1.66) 1.26 (0.88 to 1.81)
South American 899 58 0.67 (0.28 to 1.60) 1.14 (0.51 to 2.59) 73 1.05 (0.56 to 1.96) 1.08 (0.54 to 2.13)
MS indicates the morning surge in systolic blood pressure. Hazard ratios (95% CIs) express the risk in the top decile compared with the average risk in the whole
study population. The Cox models included cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease, diabetes
mellitus, antihypertensive drug treatment, 24-hour systolic blood pressure, 9 design variables coding for the deciles, and the systolic night:day blood pressure ratio.
*P0.05 hazard ratio significance.
†P0.01 hazard ratio significance.
‡P0.001 hazard ratio significance.
§Heterogeneity between corresponding subgroups (P0.04).
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blood pressure, in which all of “the results of interest”
occurred, were older, more likely to be on antihypertensive
drugs, had higher 24-hour and daytime blood pressures, and
had a lower night:day blood pressure ratio. While adjusting
for these risk factors in multivariable Cox models, the
morning surge in blood pressure in the top decile remained a
significant and independent predictor of total mortality and of
all cardiovascular and cardiac events, over and beyond classic
risk factors. Moreover, sensitivity analyses stratified for
major risk factors were also confirmatory. By and large our
current findings suggest that the morning surge in blood
pressure independently contributes to the risk stratification on
the basis of ambulatory blood pressure monitoring.
In contrast to previous studies,4,5 the morning surge in
blood pressure did not predict stroke. It is likely that the
association between stroke and the morning surge depends on
the stroke subtype.4,5 In our current study, Asians belonging
to the top decile were at a significantly higher risk of
hemorrhagic stroke (51 cases; hazard ratio [95% CI]: 2.28
[1.09 to 4.26]; P0.03) but not ischemic stroke (127 cases;
hazard ratio: 1.41 [0.67 to 2.98]; P0.37) compared with
Asians with a lesser morning surge. These results were
consistent with a previous report from the Ohasama Study4
but was different from the study of Kario et al5 in which the
sleep-through morning surge significantly predicted cerebral
infarcts. Different characteristics of the populations under
study might explain this diversity. Indeed, the study by Kario
et al5 included older hypertensive patients (mean age: 72
years). The sleep-through morning surge in systolic blood
pressure in the top decile (55 mm Hg) was greater in the
study by Kario et al5 than in our current report (35 mm Hg
in Europeans and South Americans and 43 mm Hg in
Asians).
Although the morning surge in both systolic pressure and
diastolic pressure (see Data Supplement) predicted risk, we
would suggest using only the rise in systolic blood pressure in
the morning as a risk indicator, because in middle-aged and
older subjects systolic rather than diastolic blood pressure is
the predominant risk factor.26 Using the morning surge in
blood pressure as a risk indicator requires multiple blood
pressure readings during sleep and during the preawakening
and awakening periods. Subjects also have to complete a
diary during ambulatory blood pressure monitoring to report
the sleeping and awake periods. In our database, these 2
issues eliminated 4850 of 11 786 available subjects. More-
over, according to our recently published study in older
patients with isolated systolic hypertension,27 the morning
surge in blood pressure, irrespective of its definition, was
poorly reproducible. Nearly 30% of the subjects changed
their surge status either in the short term (median: 33 days) or
in the long term (median: 10 months).27 These 3 factors might
limit the clinical application of the morning surge in blood
pressure as a cardiovascular risk factor.
The present study should be interpreted within the context
of its possible limitations. Above all, none of the included
studies was prospectively designed to evaluate the risk
associated with the morning surge in blood pressure. On the
other hand, our study was population based, prospective,
large, and sufficiently powered with 785 deaths and 611
major cardiovascular events. Second, our study population
consisted of more Europeans than Asians and South Ameri-
cans. Although we did not detect any heterogeneity in the
hazard ratios for all-cause mortality and all cardiovascular
events, our findings may need replication in other popula-
tions. Third, our study did not address the mechanisms
explaining why the morning surge behaves as an independent
predictor of mortality and cardiovascular events. Several
hypotheses have been put forward. A steep morning surge in
blood pressure might cause structural damage to the large
arteries if the pressure load during the morning period
repeatedly exceeds the buffering capacity of the arteries.
Indeed, an exaggerated pressure load leads to fracture of the
elastin fibers, to disorganization and hypertrophy of the
muscular layers of the arterial wall,28 and to plaque rupture.29
These mechanisms might be particularly active in atheroscle-
rotic arteries,28 in the presence of oxidative stress,29,30 or in
older subjects with impaired baroreflexes.31
Perspectives
Our study established the prognostic value of the morning
surge in blood pressure in general populations. An exagger-
ated morning surge, exceeding the 90th percentile of the
population, is an independent risk factor for mortality and
cardiovascular and cardiac events, especially in smokers.
Conversely, a sleep-through or preawakening morning surge
in systolic blood pressure 20 mm Hg is probably not
associated with an increased risk of death or cardiovascular
events. Additional studies are necessary to refine the exact
threshold to be used for risk stratification in clinical practice
and to replicate our findings in other ethnicities, in particular
blacks. Moreover, randomized clinical trials should investi-
gate whether drug treatment specifically intervening with the
morning surge in blood pressure might reverse the risk and
improve prognosis.
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Expanded Methods  
Study Population  
As described in detail elsewhere,1 we constructed the International Database on Ambulatory Blood 
Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO). Studies were eligible for inclu-
sion, if they involved a random population sample, if baseline information on the ambulatory blood 
pressure and cardiovascular risk factors was available, and if the subsequent follow-up included fatal 
and nonfatal outcomes. Of 13 studies,2-13 we excluded 2, because at the time of writing of this manu-
script follow-up had not yet been organized,13 or because follow-up did not include nonfatal events.12 
All studies received ethical approval and have been reported in peer-reviewed publications.  At the 
time of writing this report, the IDACO database included 11 786 subjects from 11 centers. For the 
present analysis, we selected studies in which the participants completed a diary during ambulatory 
blood pressure monitoring, leaving 8 cohorts3-10 and 9488 subjects for possible analysis. In line with 
previous analyses,14-17 we excluded 250 participants because they were younger than 18 years, and 
2430 participants because they had fewer than 10 daytime or fewer than 5 nighttime blood pressure 
readings. For analysis of the morning surge, we additionally disregarded 1163 subjects, because they 
had less than 2 blood pressure readings during the 2 hours before (n=122) or after awakening 
(n=1041). Thus, the 5645 participants included in the current analysis consisted of 1685 residents from 
Copenhagen, Denmark;8 532 subjects from Noorderkempen, Belgium;3 220 subjects from Novosibirsk, 
Russia;5,7 290 subjects from Padova, Italy;9 296 subjects from Kraków, Poland;7 1396 inhabitants from 
Ohasama, Japan;6 327 villagers from the JingNing county, China;10 and 899 subjects from Montevi-
deo, Uruguay.4
  
All participants gave informed written consent.  
Blood Pressure Measurement  
Conventional blood pressure was measured by trained observers with a mercury sphygmomanome-
ter,3,5,7-10 with validated auscultatory6 (USM-700F, UEDA Electronic Works, Tokyo, Japan) or oscil-
lometric4 (OMRON HEM-705CP, Omron Corporation, Tokyo, Japan) devices, using the appropriate 
cuff size, with participants in the sitting position.3-10 Conventional blood pressure was the average of 2 
consecutive readings obtained either at the person’s home3-5,7,9,10 or at an examination center.6,8 
Hypertension was a conventional blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic 
or the use of antihypertensive drugs.  
We programmed portable monitors to obtain ambulatory blood pressure readings at 30-minute in-
tervals throughout the whole day,6 or at intervals ranging from 158 to 203,5,7,10 minutes during daytime 
and from 306 to 608 minutes at night. The devices implemented an oscillometric technique (SpaceLabs 
90202 and 90207, SpaceLabs Inc, Redmond, USA18) in Noorderkempen,3 Montevideo,4 Novosibirsk,5 
Kraków,7 Padova,9 and JingNing.10 The Takeda TM-2421 recorders (A&D, Tokyo, Japan19) used in 
Copenhagen8 and the ABPM-630 devices (Nippon Colin, Komaki, Japan20) used in Ohasama6 im-
plemented both techniques, but only the oscillometric readings were analyzed.  
The same SAS macro processed all ambulatory recordings, which generally remained unedited. 
The Ohasama recordings were edited sparsely according to previously published criteria.21 When ac-
counting for the daily pattern of activities of the participants, we defined daytime as the interval ranging 
from 10:00 AM to 8:00 PM in Europeans3,5,7-9 and South Americans,4 and from 8:00 AM to 6:00 PM in 
Asians.6,10 The corresponding nighttime intervals ranged from midnight to 6:00 AM3-5,7-9 and from 
10:00 PM to 4:00 AM.6,10 These fixed intervals eliminate the transition periods in the morning and 
evening when blood pressure changes rapidly, resulting in daytime and nighttime blood pressure levels 
that are within 1–2 mm Hg of the awake and asleep levels.10,22 Within individual subjects, we weighted 
the means of the ambulatory blood pressure by the interval between readings. To quantify the noctur-
nal fall in blood pressure, we computed the night:day blood pressure ratio from the nighttime and day-
time blood pressures.  
For analysis of the morning surge in blood pressure, we determined the awake and asleep periods 
from the subjects’ diary cards. Subjects were asked to record the time when they got up in the morning 
and went to bed at night. The sleep-trough morning surge was the difference between the morning 
pressure (the average blood pressure during the 2 hours after awakening) and the lowest nighttime 
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blood pressure (the average of the lowest pressure and the 2 readings immediately preceding and 
following the lowest value).23 The preawaking morning surge was the difference between the morning 
blood pressure (the average blood pressure during the 2 hours after awakening) and the preawaking 
blood pressure (the average blood pressure during the 2 hours before awakening).23,24 The median 
(fifth to 95% percentiles) number of blood pressure readings for the calculation of the morning blood 
pressure and the preawaking blood pressure was 4 (2 to 6) and 5 (2 to 9), respectively. 
Other Measurements  
We used the questionnaires originally administered in each cohort to obtain information on each sub-
ject’s medical history, and smoking and drinking habits. Body mass index was body weight in kilograms 
divided by height in meters squared. We measured serum cholesterol and blood glucose by automated 
enzymatic methods. Diabetes mellitus was the use of antidiabetic drugs, a fasting blood glucose con-
centration of at least 7.0 mmol/L,3-10 a random blood glucose concentration of at least 11.1 
mmol/L,3,6,10 a self-reported diagnosis,3,4,10 or diabetes documented in practice or hospital records.4   
Ascertainment of Events   
In each cohort, outcomes were adjudicated against source documents described in previous publica-
tions.1,6,8,11,25-27 The adjudication process was the same in the Belgian study25 and all other studies 
contributing to the European Project on Genes in Hypertension (Novosibirsk, Pilsen, Padova, and 
Kraków).26 Fatal and nonfatal stroke (ICD8/9 430–434 and 436, ICD10 I60–I64 and I67–I68) did not 
include transient ischemic attacks. Coronary events encompassed death from ischemic heart disease 
(ICD8 411–412, ICD9 411 and 414, and ICD10 I20 and I24–I25), sudden death (CD8 427.2 and 795, 
and ICD9 427.5 and 798, and ICD10 I46 and R96), nonfatal myocardial infarction (ICD8/9 410, and 
ICD10 I21-I22), and coronary revascularization. Cardiac events comprised coronary endpoints and 
fatal and nonfatal heart failure (ICD8 428 and 427.1–427.2 and 429, and ICD9 429, and ICD10 I50 and 
J81). Hospitalizations for unstable angina were coded as ischemic heart disease. In the Danish and 
Swedish cohorts, the diagnosis of heart failure required admission to hospital. In the other cohorts, 
heart failure was either a clinical diagnosis or the diagnosis on the death certificate, but in all cases it 
was validated against hospital files or the records held by family doctors. The composite cardiovascular 
endpoint included all aforementioned endpoints plus cardiovascular mortality (ICD8 390–448, and 
ICD9 390.0-459.9, and ICD10 I00-I79 and R96). In all outcome analyses, we only considered the first 
event within each category.  
Statistical Analysis  
For database management and statistical analysis, we used SAS software, version 9.1.3 (SAS Insti-
tute). We compared means and proportions by the large sample z-test and the χ2-statistic, respectively. 
Statistical significance was a 2-sided P-value of 0.05. After stratification for cohort and sex, we imputed 
missing values of body mass index (n=11) and serum cholesterol (n=88) from the regression slope on 
age. In subjects with unknown smoking status (n=7) or drinking habits (n= 286), we set the design va-
riable to the cohort- and sex-specific mean of the codes (0,1).  
We used Kaplan-Meier survival function estimates and the log-rank test to compare the incidence 
rates in the top decile group of the sleep-trough and preawakening morning surge with that of the rest 
of the study population. We used Cox regression to compute hazard ratios. We checked the propor-
tional hazards assumption by the Kolmogorov-type supremum test, as implemented in the PROC 
PHREG procedure of the SAS package. Because the relation between cardiovascular complications 
and the morning surge in blood pressure was not linear, we used the deviation from population mean 
coding28 to define ethnic- and sex-specific deciles of the sleep-trough and preawakening morning 
surge. This approach expresses the risk in each decile relative to the overall risk in the whole study 
population and allows computation of confidence intervals for the hazard ratio in each decile without 
definition of an arbitrary reference group. We adjusted the hazard ratios for baseline characteristics, 
including cohort, sex, age, body mass index, the 24-h blood pressure level, current smoking, use of 
alcohol, serum cholesterol, the presence of diabetes mellitus, a history of cardiovascular disease, and 
antihypertensive treatment. In fully adjusted models, the night:day blood pressure ratio was additionally 
included as a covariable. In the sensitivity analyses, we compared the hazard ratios according to 
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baseline characteristics using a normal approximation of the log-transformed point estimates and 
standard errors.  
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Appendix  
IDACO Centers and Investigators:  
Belgium (Noorderkempen): R. Fagard, Y. Jin, T. Kuznetsova, T. Richart, J. A. Staessen, L. Thijs; China 
(JingNing): Y. Li, J. Wang; the Czech Republic (Pilsen): J. Filipovský, J. Seidlerová, M. Tichá; Denmark 
(Copenhagen): T. W. Hansen, H. Ibsen, J. Jeppesen, S. Rasmussen, C Torp-Pedersen; Italy (Padova): 
E. Casiglia, A. Pizzioli, V. Tikhonoff; Ireland (Dublin): E. Dolan, E. O’Brien; Japan (Ohasama): K. 
Asayama, J. Hashimoto, H. Hoshi, Y. Imai, R. Inoue, M. Kikuya, H. Metoki, T. Obara, T. Ohkubo, H. 
Satoh, K. Totsune; Poland (Kraków): A. Adamkiewicz-Piejko, M. Cwynar, J. Gąsowski, T. Grodzicki, K. 
Kawecka-Jaszcz, W. Lubaszewski, A. Olszanecka, K. Stolarz, B. Wizner, W. Wojciechowska, J. 
Zyczkowska; the Russian Federation (Novosibirsk): T. Kuznetsova, S. Malyutina, Y. Nikitin, E. Pello, G. 
Simonova, M. Voevoda; Sweden (Uppsala): B. Andrén, L. Berglund, K. Björklund-Bodegård, L. Lind, B. 
Zethelius; Uruguay (Montevideo): M. Bianchi, V. Moreira, E. Sandoya, C. Schettini, E. Schwedt, H. 
Senra. 
Data Base Management and Coordination:   
T. W. Hansen, M. Kikuya, Y.Li, T. Richart, J. A. Staessen (Project Coordinator), and L. Thijs (Supervi-
sor Database Management) constructed the IDACO database at the Studies Coordinating Centre in 
Leuven, Belgium.   
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Table S1. Baseline Characteristics of the Participants Categorized According to the 90th 
Percentile of the Diastolic Sleep-Trough Morning Surge  
Characteristics  
 Sleep-Trough Morning Surge 
P  
 < 28.5 mm Hg*   ≥ 28.5 mm Hg*   
Total, n   5072   573   
European   2717 (53.6)   306 (53.4)    0.99  
Asian   1548 (30.5)   175 (30.5)    0.99  
South American    807 (15.9)    92 (16.1)    0.90  
Women   2740 (54.0)   308 (53.8)    0.90  
Antihypertensive treatment   1010 (19.9)   178 (31.1)  <0.0001  
Smokers   1499 (29.6)   191 (33.3)    0.06  
Using alcohol   2424 (47.8)   243 (42.4)    0.01  
Diabetes mellitus   342 (6.7)   43 (7.5)    0.49  
Cardiovascular disorders   351 (6.9)   53 (9.3)    0.04  
Age, y     52.9±14.5    54.1±16.0    0.08  
Body mass index, kg/m2   25.1±4.2   25.6±4.4    0.009  
Conventional DBP, mm Hg    79.1±11.6    82.3±12.1  <0.0001  
Ambulatory DBP, mm Hg        
24-hour   73.3±8.5   76.8±8.2  <0.0001  
Daytime   78.2±9.2   83.1±9.3  <0.0001  
Nighttime   64.6±9.2   63.6±9.1    0.01  
Nighttime trough   60.0±9.2   55.5±8.2  <0.0001  
Preawakening    65.4±10.3    67.9±11.5  <0.0001  
After awakening    75.1±10.4    89.2±9.5  <0.0001  
Night:day ratio of DBP    0.83±0.09    0.77±0.09  <0.0001  
Serum cholesterol, mmol/L    5.56±1.19    5.57±1.16    0.91  
The 90th percentiles were determined after stratification for ethnicity and sex. Data are number (%) or mean±SD. 
DBP indicates diastolic blood pressure. P-values are for the difference between the two groups.  
* Mean values of the cut-off point across ethnicities and sex weighted for the number of participants in each of the 
strata.   
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Table S2.  Multivariable-Adjusted Hazard Ratios for the Sleep-Trough and Pre-Awakening Morning Surge in Diastolic 
Blood Pressure  
Outcomes  
(Nº of events)  
 Sleep-Trough Surge (≥28.5 mm Hg)  Pre-Awakening Surge (≥21.6 mm Hg)  
 Adjusted  Fully Adjusted   Adjusted  Fully Adjusted  
Mortality          
All causes (785)   1.34 (1.11–1.62)†  1.44 (1.18–1.75)‡   1.17 (0.95–1.45)  1.26 (1.01–1.56)*  
Cardiovascular (287)   1.48 (1.11–1.98)†  1.59 (1.17–2.15)†   1.13 (0.79–1.61)  1.24 (0.86–1.80)  
Non-Cardiovascular (473)   1.28 (0.99–1.66)  1.37 (1.05–1.78)*   1.29 (0.99–1.69)  1.37 (1.04–1.81)*  
Fatal and nonfatal events        
All cardiovascular (611)   1.10 (0.89–1.37)  1.18 (0.94–1.48)   1.12 (0.88–1.41)  1.21 (0.95–1.54)  
Cardiac (317)   1.22 (0.90–1.66)  1.31 (0.96–1.78)   1.29 (0.93–1.78)  1.40 (1.00–1.96)*  
Coronary (228)   1.14 (0.80–1.63)  1.19 (0.82–1.72)   1.15 (0.78–1.69)  1.22 (0.82–1.82)  
Cerebrovascular (281)   0.98 (0.70–1.36)  1.03 (0.73–1.46)   0.91 (0.64–1.30)  0.97 (0.67–1.40)  
Infarction (140)   0.81 (0.50–1.33)  0.85 (0.51–1.41)   0.83 (0.50–1.39)  0.89 (0.53–1.51)  
Hemorrhage (70)   1.67 (0.96–2.91)  1.57 (0.87–2.83)   1.71 (0.96–3.04)  1.62 (0.88–2.98)  
Hazard ratios (95% confidence intervals) express the risk in the top decile of the sleep-trough or preawakening morning surge in diastolic blood 
pressure compared with the overall risk in the whole study population. The Cox models included cohort, sex, age, body mass index, smoking and 
drinking, serum cholesterol, history of cardiovascular disease, diabetes mellitus, antihypertensive drug treatment, 24-hour diastolic blood pressure 
and 9 design variables coding for the deciles. In fully adjusted models, the diastolic night:day blood pressure ratio was additionally included in the 
Cox model. The cause of death was unknown in 25 cases. Significance of the hazard ratios: * P<0.05, † P<0.01, ‡ P<0.001.  
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Table S3.  Multivariable-Adjusted Hazard Ratios for the Sleep-Trough and Pre-Awakening Morning Surge in Diastolic 
Blood Pressure According to Baseline Characteristics   
Strata  All-Cause Mortality  All Cardiovascular Events  
 At risk    (n)  
Deaths  
  (n)  
Sleep-Trough MS  
 (≥28.5 mm Hg)  
Pre-Awakening MS 
  (≥ 21.6 mm Hg)  
Events  
  (n)  
Sleep-Trough MS  
 (≥ 28.5 mm Hg)  
Pre-Awakening MS  
  (≥ 21.6 mm Hg)  
All participants  5645  785  1.44 (1.18–1.75)‡  1.26 (1.01–1.56)*  611  1.18 (0.94–1.48)  1.21 (0.95–1.54)  
Women  3048 321  1.37 (1.02–1.84)*  1.38 (0.99–1.90)  251  0.99 (0.70–1.41)  1.30 (0.91–1.84)  
Men  2597 464  1.47 (1.13–1.92)†  1.16 (0.86–1.58)  360  1.27 (0.94–1.71)  1.13 (0.81–1.59)  
<60 years  3558 134  1.85 (1.14–3.00)*  1.84 (1.17–2.89)†  151  1.32 (0.83–2.10)  1.55 (1.02–2.36)*  
≥60 years  2087 651  1.37 (1.11–1.71)†  1.13 (0.88–1.45)  460  1.14 (0.88–1.48)  1.07 (0.79–1.44)  
No history of CVD  5241 660  1.41 (1.13–1.75)†  1.17 (0.92–1.49)  501  1.15 (0.90–1.49)  1.12 (0.86–1.45)†  
History of CVD  404  125  1.70 (1.04–2.79)*  1.79 (0.99–3.21)  110  1.21 (0.71–2.06)  1.60 (0.84–3.03)  
Untreated  4457  464  1.49 (1.13–1.98)†  1.25 (0.92–1.71)  332  1.24 (0.88–1.75)  1.44 (1.03–2.01)*  
Treated  1188  321  1.41 (1.07–1.85)*  1.30 (0.95–1.78)  279  1.19 (0.88–1.60)  1.06 (0.75–1.51)  
Normotensive  3340  290  1.75 (1.23–2.51)†  1.26 (0.83–1.92)  178  1.89 (1.22–2.92)†  1.72 (1.09–2.71)*  
Hypertensive  2305  495  1.35 (1.06–1.70)*  1.27 (0.98–1.64)  433  1.02 (0.79–1.33)  1.07 (0.81–1.43)  
Non-smokers 3955  485  1.34 (1.04–1.71)*  1.30 (0.97–1.74)  389  1.08 (0.82–1.44)  1.19 (0.86–1.64)  
Smokers 1690  300  1.53 (1.11–2.12)†  1.19 (0.85–1.67)  222  1.24 (0.85–1.82)  1.22 (0.84–1.78)  
Non-drinkers 2978  409  1.33 (1.02–1.74)*  1.26 (0.94–1.68)  318  1.17 (0.87–1.58)  1.15 (0.84–1.57)  
Drinkers 2667  376  1.55 (1.15–2.07)†  1.25 (0.89–1.76)  293  1.13 (0.79–1.61)  1.30 (0.88–1.92)  
European 3023  408  1.15 (0.84–1.56)  1.02 (0.73–1.43)  304  1.19 (0.85–1.69)  1.25 (0.87–1.81)  
Asian 1723  319  1.58 (1.19–2.10)†  1.42 (1.03–1.97)*  234  1.25 (0.89–1.77)  1.03 (0.69–1.52)  
South American 899   58  2.08 (1.09–3.96)*  2.47 (1.17–5.21)*   73  1.00 (0.52–1.91)  1.88 (1.03–3.42)*  
MS indicates the morning surge in diastolic blood pressure. Hazard ratios (95% confidence intervals) express the risk in the top decile compared with the 
average risk in the whole study population. The Cox models included cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of 
cardiovascular disease, diabetes mellitus, antihypertensive drug treatment, 24-hour diastolic blood pressure, 9 design variables coding for the deciles and the 
diastolic night:day blood pressure ratio. Significance of the hazard ratios: * P<0.05; † P<0.01; and ‡ P<0.001.  
 
  
  
 by JAN STAESSEN on March 8, 2010 hyper.ahajournals.orgDownloaded from 
ISSN: 1524-4563 
Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0194-911X. Online
72514
Hypertension is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX
DOI: 10.1161/HYPERTENSIONAHA.109.148908 
 published online Mar 8, 2010; Hypertension
William B. White 
 The Risk of Waking-Up. Impact of the Morning Surge in Blood Pressure
 http://hyper.ahajournals.org
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
 http://www.lww.com/reprints
Reprints: Information about reprints can be found online at 
  
 journalpermissions@lww.com
410-528-8550. E-mail: 
Fax:Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. 
Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters
  
 http://hyper.ahajournals.org/subscriptions/
Subscriptions: Information about subscribing to Hypertension is online at 
 by JAN STAESSEN on March 8, 2010 hyper.ahajournals.orgDownloaded from 
Editorial Commentary
The Risk of Waking-Up
Impact of the Morning Surge in Blood Pressure
William B. White
Through ambulatory blood pressure (BP) monitoring, weknow that BP usually follows a distinct circadian rhythm,
characterized by a nocturnal decline during sleep of 10% to
30%, followed by a moderate-to-marked increase coinciding
with the time of awakening.1 For 2 decades, there has been
great interest in the early morning period by preventive
cardiologists and hypertension specialists, because it became
evident that the onset of acute events, including sudden death,
myocardial infarction, and stroke peak in the first 4 to 6 hours
postawakening.2,3 Because BP, heart rate, and these cardio-
vascular events all follow the same temporal pattern, it has
been suspected that a pathophysiological relationship exists
between hemodynamic aberrations, such as the early morning
BP surge and vascular damage.3
Previous researchers have characterized the morning BP
surge associated with increased target organ injury.3,4 Risk
factors for a profile of excessive early morning hypertension
include older age, excessive alcohol and/or smoking, longer
sleep times and later awakening times, cold weather climates,
and day of the week (primarily Monday!).5,6 Several studies
performed in the past decade have found significant relations
among the early morning BP surge and vascular disease,7
cardiac hypertrophy,4 and white matter lesions of the brain.6,8
Prospective studies in Japanese individuals8,9 have demon-
strated a clinical impact of the early morning BP surge in
predicting cardiovascular events. In one such cohort with
3.5 years of follow-up, for each 10-mm Hg increase in the
early morning systolic BP surge obtained at baseline, the risk
of stroke increased by 22%.8 Of note, this change of BP on
arising predicted cardiovascular events independently of age,
the average 24-hour systolic BP, and antihypertensive ther-
apy. In a separate population in Ohasama, Japan, that had a
10-year median follow-up period,9 a large early morning BP
surge was associated with the development of hemorrhagic
stroke. Furthermore, in a smaller cohort study in France,10 a
higher cardiovascular morbidity and mortality rate was ob-
served in patients with the highest morning BP surge com-
pared with those patients in the lowest morning BP surge
group.
Thus, previous studies have suggested a parallel relation-
ship between the early morning BP surge and cardiovascular
outcomes but have been lacking in event numbers and enough
statistical power to clarify at just what level of the morning
BP surge the risk will appear to become excessive. In this
issue of Hypertension, Yi et al11 have used the International
Database on Ambulatory Blood Pressure in Relation to
Cardiovascular Outcome to address these questions. It is clear
that their analyses have more advantages than previous
studies: first, the population is large and heterogenous (5645
people, and more than half are women from 8 countries on 3
continents); second, the follow-up period and event numbers
are substantially greater than all of the previous studies with
11.4 years of median follow-up and 600 cardiovascular
events. The investigators used 2 different definitions of the
morning surge in BP; the first was called the “sleep-through
morning surge” and was defined as the difference between
the morning pressure during the first 2 hours after awakening
and the average of the lowest nighttime BP. This was similar
to the definition used by Kario et al8 in their seminal
description of the impact of the morning BP surge on stroke
events in an older Japanese cohort. The second definition was
the “preawakening morning surge” and was the calculated
difference between the morning BP during the first 2 hours
after awakening and the BP during the first 2 hours before
awakening. The top decile for these 2 definitions of morning
BP surge was 37 and 28 mm Hg, respectively. In addition, the
absolute morning surge in BP was 145.8 versus 123.7 mm Hg
in those subjects who were in the 90th percentile versus those
below the 90th percentile using the systolic sleep-through
morning surge definition. In general, the trends for the 2
methods were similar: the morning BP surge was associated
with a 30% to 45% increase in hazard for cardiovascular
events. Of note, both definitions were fairly robust and
similar for cardiac events but not for stroke events. The
reason for this is unclear, but the authors did note demo-
graphic differences, because subjects in Asian countries were
at a significantly higher risk for hemorrhagic stroke in the top
morning surge decile but not for ischemic strokes, a finding at
odds with the study by Kario et al.8
Of interest from the clinical perspective is the analysis of
Yi et al11 to determine the “cutoff’ point at which cardiovas-
cular harm begins to occur. Using both definitions, the
authors suggest that a systolic morning BP surge by either
definition of 20 mm Hg is unlikely to be associated with
increased risk. This is useful, and it would be important to
know what absolute systolic BP correlates with the surge
values used to plot against the adjusted hazard ratios. Lacking
in this analysis, however, is characterization of the population
as it relates to the morning BP surge. Might individuals with
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a history of previous vascular events or major cardiovascular
comorbidities (eg, diabetes mellitus or chronic kidney dis-
ease) show increased risk with lesser morning BP surge
values compared with a healthier hypertensive patient group?
A substantial number of investigations have been con-
ducted on the mechanism of the morning surge in BP and its
potential relationship to cardiovascular harm.3 Increased,
sympathetic nervous system activity and activation of the
renin-angiotensin system have both been determined to be
possible contributors to increases in vascular resistance and
the morning BP surge. Whether these mechanisms of morn-
ing BP elevation independently convey vascular harm is not
clear but is of theoretical concern, because it is known that
-adrenergic stimulation and renin-angiotensin-aldosterone
activation can increase vascular tone, coronary vasospasm,
and prothrombotic tendencies in the early morning period
(see Figure).1,3
Now that there is better characterization of the evidence
linking an exaggerated morning BP surge of 28 to 37 mm Hg
to cardiovascular morbidity and mortality, it seems reason-
able to consider targeting this time of day with antihyperten-
sive drug therapy. In fact, a substantial attempt to evaluate the
benefit of a therapy that targeted BP and heart rate in the early
morning period with controlled-onset extended-release verap-
amil versus conventional diuretic and/or -blocker therapy on
early morning cardiovascular events was initiated 12 years
ago.12 The Controlled Onset Verapamil Investigation for
Cardiovascular Endpoints Trial was a 17 000-patient study
that defined morning cardiovascular events as those occurring
in the first 6 hours postawakening and originally should have
had enough statistical power to evaluate this prespecified
outcome on targeted versus nontargeted therapy. Unfortu-
nately, because of premature discontinuation of the trial 3
years early by the study sponsor, there were not nearly
enough events to make any assessment of the early morning
event outcomes.
It seems unlikely that another large-scale trial will be
conducted to evaluate whether reduction of the morning surge
in BP will reduce cardiovascular morbidity and mortality
because, that trial would have to have an enormous sample
size and be carried out for many years at a substantial cost.
There are, however, a number of studies that demonstrate that
it may not be difficult to intervene in morning BP surge
values with targeted antihypertensive therapies.13,14
-Adrenergic blockade at bedtime13 may be an effective
means to both lower the morning BP surge and reduce left
ventricular mass index, as well as microalbuminuria, in
patients with uncontrolled “morning hypertension.” In addi-
tion, renin-angiotensin blocking agents that maintain pharma-
codynamic effects into the early morning period have been
shown to have a significant effect on the morning surge in
BP.14 Because the early morning period coincides with the
end of the dosing period of once-daily medications, attenua-
tion of antihypertensive efficacy is relatively common. On the
basis of the results of this important new study by Yi et al,11
more scrutiny should be given to control of the early morning
BP, especially in patients at high risk for cardiovascular
diseases and those who continue to smoke cigarettes.
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